John Janik is an Oncology physician affiliated with Incyte. OpenAlex indexes 213 publications with 10,629 citations (h-index 52); ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Sponsor: Incyte Biosciences International Sàrl
- INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies
Sponsor: Incyte Biosciences International Sàrl
- A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Sponsor: Incyte Biosciences International Sàrl
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Similar KOLs
Other experts from the same institution or the same specialty.
Gerard Kennealey, MD
Incyte
Thomas Hultsch
Incyte
Evan Braunstein, MD, PhD
Incyte
Lance Leopold, MD
Incyte
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”